New Insights on Early Patterns of Respiratory Disease among Extremely Low Gestational Age Newborns

Background: The analysis of early patterns of lung disease among preterm infants may help to identify predictors of pulmonary deterioration. Objectives: To analyze FIO2 requirement in the first 14 days of life among preterm infants and to find predictors of bronchopulmonary dysplasia (BPD). Methods: Retrospective cohort study. Setting: 3 Italian level III NICUs. Population: infants born between 240/7 and 276/7 weeks' gestational age (GA) who survived to 14 days. A consecutive sample of 588 infants was analyzed. Daily mode FIO2 in the first 2 weeks of life were analyzed according to the criteria defined by Laughon et al. [Pediatrics 2009;123:1124-1131], who found 3 early respiratory patterns: consistently low FIO2 (LowFIO2), pulmonary deterioration (PD), and early persistent pulmonary deterioration (EPPD). Factors associated with pulmonary deterioration were studied by univariate and multivariate analysis. Results: Forty percent of infants had low FIO2, 18% had pulmonary deterioation, 21% had early persistent pulmonary deterioration, and 21% had a previously unreported pattern (pulmonary improvement, PI). The prevalence of BPD was 7% in the LowFIO2 group, 28% in the PI group, 44% in the PD group, and 62% in the EPPD group (p = 0.000). Infants with lung deterioration were more frequently males (OR = 2.019, CI: 1.319-3.090, p = 0.001), had lower GA (OR = 0.945, CI: 0.915-0.975, p = 0.000), higher incidence of severe respiratory distress syndrome (OR = 2.956, CI: 1.430-6.112, p = 0.003), and lack of postnatal caffeine (OR = 0.167, CI: 0.052-0.541, p = 0.003). Conclusions: We report 4 distinct patterns of early respiratory disease associated with significantly different prevalence of BPD and discuss risk factors for lung deterioration.

[1]  L. Trasande,et al.  Epidemiological Characteristics and Resource Use in Neonates With Bronchopulmonary Dysplasia: 1993–2006 , 2010, Pediatrics.

[2]  P. Crowley,et al.  Prophylactic corticosteroids for preterm birth. , 2006, The Cochrane database of systematic reviews.

[3]  A. Ohlsson,et al.  Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. , 1988, Pediatrics.

[4]  R. Redline Inflammatory responses in the placenta and umbilical cord. , 2006, Seminars in fetal & neonatal medicine.

[5]  E. Park,et al.  The Association of Histological Chorioamnionitis and Antenatal Steroids on Neonatal Outcome in Preterm Infants Born at Less than Thirty-Four Weeks’ Gestation , 2012, Neonatology.

[6]  Victor R. Preedy,et al.  Handbook of anthropometry : physical measures of human form in health and disease , 2012 .

[7]  P. Donohue,et al.  The epidemiology of atypical chronic lung disease in extremely low birth weight infants , 2008, Journal of Perinatology.

[8]  F. Cools,et al.  Efficacy of a new technique – INtubate-RECruit-SURfactant-Extubate – “IN-REC-SUR-E” – in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial , 2016, Trials.

[9]  W. Göpel,et al.  Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial. , 2015, JAMA pediatrics.

[10]  H. Fischer,et al.  Avoiding Endotracheal Ventilation to Prevent Bronchopulmonary Dysplasia: A Meta-analysis , 2013, Pediatrics.

[11]  June-Dong Park,et al.  Risk factors for the different types of chronic lung diseases of prematurity according to the preceding respiratory distress syndrome , 2005, Pediatrics international : official journal of the Japan Pediatric Society.

[12]  Yunlong Wang Chapter 2 Use of Percentiles and Z-Scores in Anthropometry , 2011 .

[13]  F. Malone,et al.  Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study. , 2013, American journal of obstetrics and gynecology.

[14]  B. Haglund,et al.  Perinatal conditions related to growth restriction and inflammation are associated with an increased risk of bronchopulmonary dysplasia , 2015, Acta paediatrica.

[15]  D. Grier,et al.  Effects of Glucocorticoids on Fetal and Neonatal Lung Development , 2004, Treatments in respiratory medicine.

[16]  B. Poindexter,et al.  Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012 , 2016 .

[17]  A. Soraisham,et al.  Association Between Antenatal Corticosteroid Administration-to-Birth Interval and Outcomes of Preterm Neonates , 2015, Obstetrics and gynecology.

[18]  P. Crowley Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. , 1995, American journal of obstetrics and gynecology.

[19]  W. Poole,et al.  Delivery Room Continuous Positive Airway Pressure/Positive End-Expiratory Pressure in Extremely Low Birth Weight Infants: A Feasibility Trial , 2004, Pediatrics.

[20]  M. Moore,et al.  Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. , 2002, The Journal of pediatrics.

[21]  J. Marks,et al.  Factors affecting the sex differential in neonatal mortality: the role of respiratory distress syndrome. , 1985, American journal of obstetrics and gynecology.

[22]  R. Ehrenkranz,et al.  Patterns of Respiratory Disease During the First 2 Postnatal Weeks in Extremely Premature Infants , 2009, Pediatrics.

[23]  E. Jensen,et al.  Effects of Multiple Ventilation Courses and Duration of Mechanical Ventilation on Respiratory Outcomes in Extremely Low-Birth-Weight Infants. , 2015, JAMA pediatrics.

[24]  M. Nishihara,et al.  Perinatal factors associated with long-term respiratory sequelae in extremely low birthweight infants , 2015, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[25]  D. Phelps,et al.  Atypical Chronic Lung Disease Patterns in Neonates , 1999, Pediatrics.

[26]  L. Nelin,et al.  Early extubation attempts reduce length of stay in extremely preterm infants even if re-intubation is necessary. , 2015, Journal of neonatal-perinatal medicine.

[27]  F. Schena,et al.  Association between Hemodynamically Significant Patent Ductus Arteriosus and Bronchopulmonary Dysplasia. , 2015, The Journal of pediatrics.